Literature DB >> 29240776

Microbiological profile and risk factors for in-hospital mortality of infective endocarditis in tertiary care hospitals of south Vietnam.

Hoang M Tran1, Vien T Truong1, Tam M N Ngo1, Quoc P V Bui1, Hoang C Nguyen1, Trung T Q Le1, Wojciech Mazur2, Eugene Chung2, John M Cafardi2, Khanh P N Pham1, Hoang H N Duong1, Thach Nguyen3, Vu T Nguyen1, Vinh N Pham1.   

Abstract

OBJECTIVES: We aimed to evaluate the microbiological characteristics and risk factors for mortality of infective endocarditis in two tertiary hospitals in Ho Chi Minh City, south Vietnam.
MATERIALS AND METHODS: A retrospective study of 189 patients (120 men, 69 women; mean age 38 ± 18 years) with the diagnosis of probable or definite infective endocarditis (IE) according to the modified Duke Criteria admitted to The Heart Institute or Tam Duc Hospital between January 2005 and December 2014.
RESULTS: IE was related to a native valve in 165 patients (87.3%), and prosthetic valve in 24 (12.7%). Of the 189 patients in our series, the culture positive rate was 70.4%. The most common isolated pathogens were Streptococci (75.2%), Staphylococci (9.8%) followed by gram negative organism (4.5%). The sensitivity rate of Streptococci to ampicillin, ceftriaxone or vancomycin was 100%. The rate of methicillin resistant Staphylococcus aureus was 40%. There was a decrease in penicillin sensitivity for Streptococci over three eras: 2005-2007 (100%), 2008-2010 (94%) and 2010-2014 (84%). The in-hospital mortality rate was 6.9%. Logistic regression analysis found prosthetic valve and NYHA grade 3 or 4 heart failure and vegetation size of more than 15 mm as strong predictors of in-hospital mortality.
CONCLUSION: Streptococcal species were the major pathogen of IE in the recent years with low rates of antimicrobial resistance. Prosthetic valve involvement, moderate or severe heart failure and vegetation size of more than 15 mm were independent predictors for in-hospital mortality in IE.

Entities:  

Mesh:

Year:  2017        PMID: 29240776      PMCID: PMC5730146          DOI: 10.1371/journal.pone.0189421

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Despite major advances in therapeutic and diagnostic options, mortality and morbidity associated with infective endocarditis (IE) has not decreased significantly in the past four decades [1]. This may be related to factors such as increased frequency of age-related valvular degeneration, prosthetic-valve surgery, and hospital-related infections that change the microbial flora and antibiotic susceptibility [1-4]. Classically, Streptococci have been the main causative microorganisms of IE. However, recent studies have shown a significant increase in frequency of Staphylococcus aureus, up to 30% of cases [1]. As recent IE treatment recommendations are significantly based on non-randomized studies and expert opinion [5, 6], empiric antibiotic therapy is usually applied based on local microbiological characteristics. For this reason, it is essential to periodically update information about regional IE pathogen characteristics and antibiotic susceptibility profile. The aim of this study was to evaluate the microbiological characteristics as well as factors associated with increased in-hospital mortality in patients hospitalized for infective endocarditis at two tertiary care hospitals in South Vietnam.

Materials and methods

Study design

This study was performed at Heart Institute and Tam Duc Hospital of Cardiology, which are tertiary care referral hospitals located in Ho Chi Minh City, South Vietnam, between 01/01/2005 to 12/31/2014. The hospital charts of patients admitted with a diagnosis of IE according to the modified Duke criteria [6, 7] were retrospectively reviewed. Patients with lack of microbiological results were excluded. A total of 189 consecutive patients with diagnosis of definite or probable IE were eligible for inclusion with 17 patients excluded from study because of lack of microbiologic data. This study was approved by the institutional review board (IRB) of Pham Ngoc Thach university of medicine as well as IRB of Heart Institute and Tam Duc Hospital of Cardiology. Informed consent was waived because of the retrospective nature of the study. The following variables were collected for each patient: Clinical background: age, sex, factors predisposing to infective endocarditis (valvular heart diseases, congenital heart diseases, prosthetic valve, pacemaker implantation, history of injection drug use), history of cardiac surgery, medical comorbidities (including diabetes, hypertension, chronic kidney disease and ischemic heart disease), clinical signs and symptoms and the presence of systemic embolic disease. Abnormal laboratory data: acute renal failure (increase of serum creatinine > 26.5 μmol/l within 48 hours), white blood cell count (WBC) > 11.000 cells/L, C reactive protein (CRP) concentration > 100 mg/l. Findings on ECG: any rhythm other than sinus tachycardia (heart rate > 100 beats/min). Findings on echocardiography: location of visible vegetation, vegetation size, vegetation number, valve type, impaired left ventricular function (ejection fraction < 40%), congenital heart diseases, intracardiac complications of infective endocarditis.

Statistical analysis

Continuous variables are expressed as mean ± standard deviation (SD) for normal distributions and median + interquartile range for non-normal distributions. Categorical variables were represented as frequencies and percentages. For the evaluation of qualitative variables, we used the Chi-Square test. To test for significant differences between continuous variables in two groups, independent sample t-tests were performed. The patient variables that were analyzed in the univariate analysis included age, gender, valve type, heart failure, systemic emboli, conduction abnormalities, congenital heart diseases, WBC, CRP, acute renal failure, vegetation site, vegetation size, ejection fraction, intracardiac complications, positive blood culture, Staphylococcus aureus infection. Logistic regression analysis was performed to identify independent prognostic factors for death. [8]. Statistical analysis was performed using the SPSS 22 software program (SPSS Inc., Chicago, IL, USA). A p value of < 0.05 was considered statistically significant.

Results

Baseline characteristics

During this 10-year period, a total of 189 consecutive patients with diagnosis of definite or probable IE were identified (S1 File). Baseline characteristics, predisposing conditions, clinical findings on admission for the 189 IE cases are shown in Table 1. The mean age of patients was 37.6 ± 18.0 years with 120 men (63.5%) and 69 women (36.5%).
Table 1

Characteristics of study sample.

Featuresn (%)Featuresn (%)
Clinical backgroundSymptoms and signs
Valvular heart diseases125 (66.1)Fever168 (88.9)
Congenital heart diseases36 (19.1)Fever duration (days) before admission26.69 ± 24.64
Prosthetic valve24 (12.7)Rigors15 (7.9)
Pacemakers implantation4 (2.1)Dyspnea66 (34.9)
History of cardiac surgery33 (17.5)Anorexia10 (5.3)
History of infective endocarditis12 (6.3)Weight loss12 (6.3)
Intravenous drug user2 (1.1)Fatigue46 (24.3)
Previous antibiotic usage46 (24.3)Cardiac murmur115 (60.8)
Hypertension21 (11.1)Hepatomegaly21 (11.1)
Diabetes2 (1.1)Splenomegaly6 (3.2)
Chronic kidney disease2 (1.1)Roth spot6 (3.2)
Ischemic heart disease3 (1.6)Osler’s node1 (0.5)
Skin rash4 (2.1)
Embolisms19 (10.1)
Cardiac conduction disorder7 (3.7)

Categorical variables are presented as n (%)

Categorical variables are presented as n (%) 33 patients (17.5%) had a history of cardiac surgery while 2 patients (1.1%) had a history of intravenous drug abuse. Only 2 patients (1.1%) had diabetes while none had end-stage renal disease. Predisposing valvular heart disease was found in 125 (66.1%) and congenital heart diseases in 36 (19.1%) of the patients. Prosthetic cardiac valves were present in 24 (12.7%) and 4 (2.1%) patients experienced pacemaker lead IE (Table 1). In our study, vegetation was observed in 172 cases (91%), of whom 14 (7.4%) were found to have large vegetation (>15 mm). Affected valves were mitral valve in 78 (41.3%), aortic valve in 38 (20.1%), mitral and aortic valves in 11 (5.8%), tricuspid valve in 8 (4.2%) patients, pulmonary valve in 6 (3.2%) patients and right ventricular wall in 15 (7.9%) patients. Other vegetation sites were observed in 16 patients (8.5%) (Table 2).
Table 2

Echocardiographic findings of the study sample.

Vegetation numbern (%)Vegetation siten (%)
    017 (9.0)Mitral78 (41.3)
    187 (46.0)Aortic38 (20.1)
246 (24.3)Mitral and aortic11 (5.8)
≥ 339 (20.7)Tricuspid8 (4.2)
Vegetation sizen (%)Pulmonary6 (3.2)
≤ 10mm116 (61.4)Tricuspid and pulmonary valve2 (1.1)
    10-15mm59 (31.2)Left and right sides5 (2.6)
    >15mm14 (7.4)Right ventricular wall15 (7.9)
Intracardiac complicationsn (%)Pulmonary arterial wall6 (3.2)
Valve leaflet perforation41 (62.1)Left ventricular wall1 (0.5)
Chordae tendinae rupture20 (30.3)Pacemaker wire2 (1.1)
Paravalvular abscess19 (28.8)No vegetation17 (9.0)
Prosthetic valve dehiscence3 (4.5)

Categorical variables are presented as n (%)

Categorical variables are presented as n (%)

Microbiological data

Blood cultures were performed in all patients, with a positive rate of 70.4% (133 patients). There was a significant difference in positive culture rate between patients with or without prior antibiotic use before admission (50% and 76.9%, respectively; p = 0.001). Streptococci remained the most common causative agent of IE (75.2%), with Staphylococcal species identified in 13 patients (9.8%). Eleven of these 13 patients had Staphylococcus aureus (Table 3).
Table 3

Causative microorganisms of 133 cases of culture positive infective endocarditis.

PathogensCases (n)(%)
Streptococci10075.2
Viridans group Streptococci9168.4
Other Streptococci96.8
Staphylococci139.8
Staphylococcus aureus11
Staphylococcus epidermidis2
Enterococcus faecalis53.8
Gram negative bacteria64.5
Pseudomonase aeruginosa2
Stenotrophomonas maltophilia1
Burkholderia cepacia2
Acinetobacter baumani1
Anerobic bacteria21.5
Gemella hemolysans1
Gemella morbillorum1
Other agents43.0
Chryseobacterium indologenes1
Granulicatella adiacens1
Haemophilus influenzae1
Weeksella virosa1
Candida spp.32.2

Categorical variables are presented as n (%)

Categorical variables are presented as n (%) Over the three time periods examined, no significant changes were observed regarding infectious endocarditis microbiology (p = 0.059) apart from an increased frequency of Staphylococcal infection in the last period (18.2% versus 4.7% and 2.9%) (Table 4). The data showed no statistically significant differences regarding the causative pathogens rate between the groups of patients having early and late infective endocarditis (p = 0.1). However, there was a higher rate of Staphylococcal infection in patients having prosthetic valve compared to native valve (16.7% versus 9.1%, P = 0.01) (Table 4). Methicillin-resistant staphylococcus aureus (MRSA) accounted for 40% of Staphylococcus aureus. Streptococcal species were sensitive to ceftriaxone, ampicillin and vancomycin in 100% of cases; they were sensitive to penicillin 92.7% of the cases.
Table 4

Causative microorganisms over the three time periods.

Causative microorganismsValve natureTime to IEVegetation sitePeriod
Native valve IEProsthetic valveEarly IELate IELeft side IERight side IEBoth sides2005–20072008–20102011–2014
Streptococci9462767222313435
(77.7)(50)(18.2)(77.8)(82.7)(64.7)(40)(88.6)(79.1)(63.6)
Staphylococci112414611210
(9.1)(16.7)(36.4)(11.1)(4.9)(17.6)(20)(2.9)(4.7)(18.2)
Gram negative bacilli4220410042
(3.3)(16.7)(18.2)(0)(4.9)(2.9)(0)(0)(9.3)(3.6)
Other bacteria11010442227
(9.1)(0)(9.0)(0)(4.9)(11.8)(40)(5.7)(4.7)(12.7)
Candida spp.1221210111
(0.8)(16.7)(18.2)(11.1)(2.5)(2.9)(0)(2.9)(2.3)(1.8)
Total1211211981345354355
(100)(100)(100)(100)(100)(100)(100)(100)(100)(100)

In-hospital mortality and predictive factors

Thirteen of 189 patients died (6.9%) during their hospital stay. In the univariate analysis, risk factors that increased mortality were: prosthetic valve involvement, severe heart failure (NYHA classification 3 or 4), systemic emboli complication, conduction abnormalities, acute renal failure, vegetation size > 15 mm, intracardiac complications, undefined microorganism by blood culture (Table 5). While, prosthetic valve involvement (OR = 34.97, P = 0.006) and severe heart failure (NYHA 3, 4) (OR = 21.91, P = 0.01), vegetation size > 15 mm (OR = 23.29, p = 0.029) were important independent risk factors for mortality in adjusted analysis.
Table 5

Factors associated with in-hospital mortality, unadjusted.

FactorCategoryNumberDeaths (%)OR95% CIP value
Age (years)<5514610 (6.8)10.27–3.890.977
≥55433 (7.0)1.02
GenderFemale692 (2.9)10.73–15.720.120
Male12011 (9.2)3.38
Valve typeNative valve1657 (4.2)12.28–24.840.001
Prosthetic valve246 (25)7.52
Heart failure gradeNYHA ≤ 21423 (2.1)13.28–47.83<0.0001
NYHA 3, 44710 (21.3)12.52
Systemic emboliNo1759 (5.1)11.93–28.160.003
Yes144 (28.6)7.38
Conduction abnormalitiesNo18210 (5.5)12.54–65.650.002
Yes73 (42.9)12.9
Congenital heart diseaseNo15311 (7.2)10.16–3.590.728
Yes362 (5.6)0.76
Elevated leucocyte countNo864 (4.7)10.58–6.610.276
Yes1039 (8.7)1.96
Elevated CRPNo1419 (6.4)10.41–4.770.594
Yes464 (8.7)1.4
Acute renal failureNo1598 (5.0)11.14–12.470.029
Yes305 (16.7)3.78
Vegetation size≤ 15 mm1759 (5.1)11.93–28.160.003
>15 mm144 (28.6)7.38
Vegetation sitePure left IE1288 (6.2)10.17–3.990.796
Pure right IE392 (5.1)0.81
Ejection fraction≥ 40%18212 (6.6)10.83–240.770.067
< 40%21 (50)14.17
Intracardiac complicationsNo1223 (2.5)11.84–26.270.004
Yes6710 (14.9)6.96
Blood culturePositive1335 (3.8)11.33–13.690.015
Negative568 (14.3)4.27
Staphylococcus aureusNo17812 (6.7)10.16–11.730.766
Yes111 (9.1)1.38

Categorical variables are presented as n (%); OR: odds ratio; CI: confidence interval

Categorical variables are presented as n (%); OR: odds ratio; CI: confidence interval

Discussion

The mean age of patients in our study was 37.6 ± 18.0 years. Published studies from developing countries also reported that patients with IE were mostly young [9-11]. Letaief et al reported on the epidemiology of infective endocarditis in Tunisia, showing a mean age of 32.4 ± 16.8 years [11]. This is contrast to data from developed countries which consistently report an older population with IE (median age 57.9 (IQR 43.2–71.8) years) [2]. This may be explained by high prevalence of rheumatic heart disease in Vietnam, whereas degenerative valve disease was the most common form of valvular disease in developed countries [2]. A Turkish study showed that the main factor contributing to younger patient age in IE could be the higher rate of rheumatic heart disease [12]. Mirabel et al studied infective endocarditis in the Lao PDR found patients with IE were mostly younger, and the most predisposing condition was rheumatic heart disease [9]. Echocardiography plays a key role in the diagnosis of IE. It is very useful to identify vegetations associated with IE as well as the assessment of complications of the disease. TEE is superior to TTE for detection of valvular vegetation as well as cardiac complications such as abscess, valvular leaflet perforation, chordae tendinae rupture and pseudoaneurysm [13, 14]. In our study, the vegetation rate was found up to 91%. Regarding to vegetation site, mitral valve was the most commonly affected valve, followed by the aortic valve, which is similar to the reports from the previous study [15]. The culture positive rate was 70.4%. This rate is higher than many studies from other developing countries [9, 10] but remains lower than those from developed countries [16, 17]. The high negative blood culture in our study can be explained by patients’ self-medication with antibiotics, which is common in Vietnam [18-20]. In addition, detection of fastidious organisms is challenging with the use of conventional blood culture techniques, as isolation of these organisms requires special media or cell culture conditions. In addition, we lacked other techniques used to diagnose the pathogens of culture negative IE such as serological analysis for Coxiella burnetii and Bartonella species, polymerized chain reaction assays for T. whipplei or Bartonella and ribosomal RNA PCR assays on valvular specimens [21]. Under these conditions, our findings showed the most frequent causative microorganism to be Streptococci (75.2%), Staphylococci (9.8%), and gram negative bacilli (4.5%). With regard to the microbiology of IE over the three time periods, no significant changes were observed regarding infectious endocarditis microbiology, although there has been an increasing frequency of Staphylococcal species. The high prevalence of Streptococcal species in our study differs from the high rates of Staphylococcal infection noted in recent studies from the developed world [2, 16, 17]. There are several reasons for this discrepancy. First, the patients in this study had a lower mean age and a higher prevalence of rheumatic heart disease, however they had lower rates of persistent bacteremia, hemodialysis, diabetes, and intravascular devices, which are key risk factors associated with IE due to Staphylococcus aureus [22]. Second, the oral health status of the Vietnamese population is sub-optimal [23, 24], which is a key predisposing cause of IE. That could also explain why Streptococci, especially viridans group Streptococci was the most common observed pathogen. Finally, prosthetic valve prevalence, intravenous line-related IE and injection drug abuse was low compared with other studies. Antimicrobial resistance was not a major problem among the microorganisms isolated from community-acquired endocarditis in our study. All Streptococci were sensitive to ampicillin, ceftriaxone, and vancomycin, while there was a mildly reduced susceptibility to penicillin, consistent with the worldwide increase in penicillin resistant viridans group Streptococci. For Staphylococci, all isolates were susceptible to vancomycin and teicoplanin, but there was high rate of methicillin resistant Staphylococcus aureus (40%). We suspect that the higher rate of methicillin resistance in our study reflects in part the widespread consumption of antimicrobials in the community in Vietnam, although this is consistent with the increased rate of methicillin resistance observed worldwide. Our study shows in-hospital mortality rate of 6.9%, which is lower than previous reports [2, 25, 26]. The characteristic of our study sample which includes mostly younger patients affected by Streptococcal infections with lower rate of comorbidities likely explains the low observed mortality. Indeed, viridans Streptococcal IE has been documented as having a good prognosis versus other pathogens [2], as well as younger age [2, 26]. In our study, several factors were associated with in-hospital mortality, including moderate or severe heart failure, prosthetic valve involvement, systemic emboli complication, conduction abnormalities, vegetation length, intracardiac complication and negative blood culture. The strong predictors were prosthetic valve involvement, moderate or severe heart failure, vegetation size > 15 mm. Congestive heart failure has been repeatedly reported as the common cause of death in infective endocarditis [27-29]. Prosthetic valve involvement and vegetation length > 15 mm were also associated with mortality in previous studies [10, 27]. Published studies have found other predictors of mortality. Hasbun et al found abnormal mental status, moderate to severe heart failure, comorbidity, staphylococcal infection, and medical therapy without valve surgery were independent predictors for mortality at 6 months [28]. In addition, Thuny et al showed that clinical indicies such as age, female sex, creatinine serum > 2mg/l, moderate or severe congestive heart failure, staphylococcal infection and vegetation length > 15 mm were strong predictor of 1-year mortality [27]. In conclusion, in this Vietnamese population in recent years, streptococcal species were the major pathogen associated with IE with low rates of observed antimicrobial resistance. Prosthetic valve involvement, moderate or severe heart failure and vegetation size > 15 mm were the most important independent predictors for in-hospital mortality in IE.

Study limitations

The main limitation of this study is that the data were collected from only 2 tertiary care hospitals. Other than the relatively small sample size, there may also be a referral bias, and we cannot conclude patients with IE in the broader communities of Vietnam. The relatively low frequency of injection drug use may be due to reporting bias. We also cannot exclude selection bias, that is that the most severe cases of IE died before diagnosis and transport to our hospitals. The risk factors for in-hospital mortaliy may not be reliable due to the low mortality rate, which leads to wide 95% confidence interval. Finally, the retrospective study design does not allow rigorous long term follow up of patients.

Raw dataset of the study.

(XLS) Click here for additional data file.
  29 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Diagnostic accuracy of transthoracic and multiplane transesophageal echocardiography for valvular perforation in acute infective endocarditis: correlation with anatomic findings.

Authors:  S De Castro; D Cartoni; G d'Amati; S Beni; J Yao; M Fiorell; P Gallo; F Fedele; N G Pandian
Journal:  Clin Infect Dis       Date:  2000-05       Impact factor: 9.079

3.  New guidelines for infective endocarditis: a call for collaborative research.

Authors:  Christoph K Naber; Raimund Erbel; Larry M Baddour; Dieter Horstkotte
Journal:  Int J Antimicrob Agents       Date:  2007-03-29       Impact factor: 5.283

Review 4.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

5.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

6.  Oral health status of adults in Southern Vietnam - a cross-sectional epidemiological study.

Authors:  Thoa C Nguyen; Dick J Witter; Ewald M Bronkhorst; Nhan B Truong; Nico H J Creugers
Journal:  BMC Oral Health       Date:  2010-03-13       Impact factor: 2.757

7.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

Authors:  David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell
Journal:  Arch Intern Med       Date:  2009-03-09

8.  Oral health status of Vietnamese children: findings from the National Oral Health Survey of Vietnam 1999.

Authors:  Andrew John Spencer; Kaye Frances Roberts-Thomson
Journal:  Asia Pac J Public Health       Date:  2009-07-02       Impact factor: 1.399

9.  Changing profile of infective endocarditis: results of a 1-year survey in France.

Authors:  Bruno Hoen; François Alla; Christine Selton-Suty; Isabelle Béguinot; Anne Bouvet; Serge Briançon; Jean-Paul Casalta; Nicolas Danchin; François Delahaye; Jerome Etienne; Vincent Le Moing; Catherine Leport; Jean-Luc Mainardi; Raymond Ruimy; François Vandenesch
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

10.  Characteristics of Infective Endocarditis in a Tertiary Hospital in East China.

Authors:  Huimin Xu; Siyu Cai; Haibin Dai
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

View more
  5 in total

Review 1.  Impact of native and external factors on exosome release: understanding reactive exosome secretion and its biogenesis.

Authors:  Harini Hariharan; Yasodha Kesavan; Natesan Sella Raja
Journal:  Mol Biol Rep       Date:  2021-10-09       Impact factor: 2.316

2.  A changing profile of infective endocarditis at a tertiary hospital in China: a retrospective study from 2001 to 2018.

Authors:  Zuning Ren; Xichao Mo; Hongjie Chen; Jie Peng
Journal:  BMC Infect Dis       Date:  2019-11-08       Impact factor: 3.090

3.  Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis.

Authors:  Rosa Zampino; Fabian Patauner; Arta Karruli; Domenico Iossa; Maria Paola Ursi; Lorenzo Bertolino; Anna Maria Peluso; Fabiana D'Amico; Giusi Cavezza; Emanuele Durante-Mangoni
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

Review 4.  Infective endocarditis in developing countries: An update.

Authors:  Reuben K Mutagaywa; Josephine C Vroon; Lulu Fundikira; Anna Maria Wind; Peter Kunambi; Joel Manyahi; Apollinary Kamuhabwa; Gideon Kwesigabo; Steven A J Chamuleau; Maarten J Cramer; Pilly Chillo
Journal:  Front Cardiovasc Med       Date:  2022-09-12

5.  Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis.

Authors:  Carmen Hidalgo-Tenorio; Juan Gálvez; Francisco Javier Martínez-Marcos; Antonio Plata-Ciezar; Javier De La Torre-Lima; Luis Eduardo López-Cortés; Mariam Noureddine; José M Reguera; David Vinuesa; Maria Victoria García; Guillermo Ojeda; Rafael Luque; José Manuel Lomas; Jose Antonio Lepe; Arístides de Alarcón
Journal:  BMC Infect Dis       Date:  2020-02-21       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.